Which has the lower trailing P/E, TMDX or UHS?

UHS has the lower trailing P/E: TMDX trades at 24.34 and UHS at 7.07. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, TMDX or UHS?

Over the past five years, TMDX grew revenue faster — TMDX at a 86.12% CAGR versus UHS at 8.21%.

Does TMDX or UHS pay a bigger dividend?

UHS pays a dividend (0.46% yield), while TMDX has no payments in the available dividend history.

Is TMDX or UHS more profitable?

TMDX runs the higher net margin — TMDX at 22.69% versus UHS at 8.42%.

How have TMDX and UHS total returns compared?

Over the past 5 years, TMDX delivered 29.39% and UHS delivered 4.02% annualized total return. Past performance doesn't predict future results.

TransMedics Group, Inc. (TMDX) vs Universal Health Services, Inc. (UHS)

A side-by-side comparison of TransMedics Group, Inc. and Universal Health Services, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 20, 2026. Differences are shown without an overall score or investment verdict.

TMDX

TransMedics Group, Inc.

$3.25B

$93.97HealthcareAt close: Aug 19, 2026, 4:00 PM ET

UHS

Universal Health Services, Inc.

$10.43B

$172.33HealthcareAt close: Aug 19, 2026, 4:00 PM ET

Total return — TMDX vs UHS

growth of $100 · dividends reinvested · last 7y

TMDX +320.3% (+22.8%/yr)UHS +42.9% (+5.2%/yr)TMDX compounded faster over this window

TMDX UHS

TMDX vs UHS: by the numbers

•UHS is the larger company ($10.43B vs $3.25B market cap).
•UHS trades at the lower trailing earnings multiple (7.07 vs 24.34 P/E), one valuation lens rather than an overall verdict.
•TMDX converts more revenue to profit (22.69% vs 8.42% net margin).
•TMDX grew revenue faster over the past five years (86.12% vs 8.21% CAGR).
•UHS pays a dividend (0.46% yield), while TMDX has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	TMDX	UHS
P/E ratio	24.34	7.07
Forward P/E	60.52	7.62
P/S ratio	5.72	0.57
P/B ratio	7.38	1.37
EV / EBITDA	35.76	5.72
FCF yield	2.07%	8.01%

Profitability

Metric	TMDX	UHS
Gross margin	58.69%	90.69%
Operating margin	12.21%	11.36%
Net margin	22.69%	8.42%
ROE	29.28%	20.31%
ROIC	5.87%	11.74%

Dividends

Metric	TMDX	UHS
Dividend yield	N/A	0.46%
Payout ratio	N/A	3.42%

Growth (annualized)

Metric	TMDX	UHS
Revenue CAGR (5Y)	86.12%	8.21%
EPS CAGR (5Y)	N/A	16.19%
FCF CAGR (5Y)	N/A	-12.18%
Total return CAGR (5Y)	29.39%	3.24%

Frequently asked

Which has the lower trailing P/E, TMDX or UHS?: UHS has the lower trailing P/E: TMDX trades at 24.34 and UHS at 7.07. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, TMDX or UHS?: Over the past five years, TMDX grew revenue faster — TMDX at a 86.12% CAGR versus UHS at 8.21%.
Does TMDX or UHS pay a bigger dividend?: UHS pays a dividend (0.46% yield), while TMDX has no payments in the available dividend history.
Is TMDX or UHS more profitable?: TMDX runs the higher net margin — TMDX at 22.69% versus UHS at 8.42%.
How have TMDX and UHS total returns compared?: Over the past 5 years, TMDX delivered 29.39% and UHS delivered 4.02% annualized total return. Past performance doesn't predict future results.

Go deeper

Full TMDX analysis Full UHS analysis Interactive comparison tool

Dig into the metrics

TransMedics P/E ratio Universal Health Services P/E ratio Universal Health Services dividend yield TransMedics ROE Universal Health Services ROE TransMedics operating margin Universal Health Services operating margin TransMedics revenue growth Universal Health Services revenue growth TransMedics free cash flow Universal Health Services free cash flow

TransMedics & Universal Health Services appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest FCF Yield Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 20, 2026.